Dana-Farber Cancer Institute

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Dana-Farber Cancer Institute

https://www.dana-farber.org/

LYNKED IN Patient Conference 2024
Multiple Myeloma Patient Symposium
2023-2024 EMBRACE MBC Virtual Forum Series
ASCO® GU 2024
ASCO® 2023
COVID-19
Leukemia
Lymphoma
Myeloma
MDS and MPN
Breast
Lung
Gynecologic
Genitourinary
Gastrointestinal
Colorectal
Basic Science
Supportive and Palliative Care
CNS
Skin
Head and Neck
Business

ASCO® 2023 Summary: "Prostate Cancer Updates From The Recent Trials"

By Dana-Farber Cancer Institute FEATURING Jacob Berchuck, Mary-Ellen Taplin

186 views

July 21, 2023

Comments 0

Hypothetical Patient Case: Hepatocellular Carcinoma with Progression…

Feat. J. Gutierrez, J. Strauss

Hypothetical Patient Case: Hepatocellular Carcinoma and Consideratio…

Feat. J. Gutierrez, J. Strauss

ASCO® 2023

ASCO® 2023 Summary: "RCC Updates From The Recent Trials"

Dana-Farber Cancer Institute

W. Xu, T. Choueiri

242 views

ASCO® 2023 Summary: "Prostate Cancer Updates From The Recent Trials"

Dana-Farber Cancer Institute

J. Berchuck, M. Taplin

186 views

ASCO® 2023 Summary: "Bladder Cancer Updates From The Recent Trials"

Dana-Farber Cancer Institute

C. Mantia, J. Bellmunt

118 views

ASCO® 2023 Insights: "Optimizing Therapy Selection for Patients With…

Insights from 2023 ASCO® Annual Meeting

B. McGregor

454 views

INSIGHT Study - Ripretinib vs. Sunitinib in Patients With Advanced G…

Insights from 2023 ASCO® Annual Meeting

S. George

126 views

ASCO® 2023 Insights: "Key Head & Neck Data"

ecancer

G. Hanna

511 views

ASCO® 2023 Insights: "INDIGO Trial on Vorasidenib vs. Placebo in Pat…

Dana-Farber Cancer Institute

P. Wen

135 views

ASCO® 2023 Insights: "Dose Expansion Results of the Bifunctional EGF…

Dana-Farber Cancer Institute

G. Hanna

60 views

ASCO® 2023 Insights: "Initial Chemo for Locally Advanced & Metastati…

Dana-Farber Cancer Institute

J. Luo

59 views

ASCO® 2023 Insights: "Effect of a Telephone-Based Weight Loss Interv…

Dana-Farber Cancer Institute

J. Ligibel

21 views

ASCO® 2023 Insights: "Prognosis & Trends in Adjuvant Chemo Use for P…

Dana-Farber Cancer Institute

P. Tarantino

92 views

ASCO® 2023 Insights: "TROPiCS-02 Final OS Analysis of Sacituzumab Go…

Dana-Farber Cancer Institute

S. Tolaney

177 views

ASCO® 2023 Insights: "Phase 3 CONTACT-03 Study - Efficacy & Safety o…

ecancer

T. Choueiri

332 views

ASCO® 2023 Insights: "CONTACT-03 Study: Efficacy and Safety of Atezo…

Dana-Farber Cancer Institute

T. Choueiri

87 views

ASCO® 2023 Insights: "Prognostic Impact of PSA Nadir (n)≥0.1ng/mL Wi…

Dana-Farber Cancer Institute

P. Ravi

121 views

ASCO® 2023 Insights: "Association of Host Immune Signatures With Res…

Insights from 2023 ASCO® Annual Meeting

E. Saad

89 views

ASCO® 2023 Insights: "Long-Term Safety of Avelumab 1L Maintenance fo…

Insights from 2023 ASCO® Annual Meeting

J. Bellmunt

84 views

ASCO® 2023 Insights: "Cabozantinib, Nivolumab, and Ipilimumab for Ad…

Insights from 2023 ASCO® Annual Meeting

B. McGregor

701 views